Dual-Loaded Chitosan-Based Nanoparticles: A Novel approach for treating polymicrobial osteomyelitis

Area of Science:

• Biomaterials Science
• Nanotechnology
• Infectious Diseases

Background:

• Osteomyelitis caused by polymicrobial infections presents a significant therapeutic challenge.
• Current treatments often struggle to effectively target both bacterial and fungal pathogens simultaneously.
• Novel drug delivery systems are needed to improve treatment efficacy for complex bone infections.

Purpose of the Study:

• To develop and characterize monodispersed chitosan nanoparticles co-loaded with minocycline (antibacterial) and voriconazole (antifungal).
• To evaluate the in vitro anti-biofilm activity of the dual-loaded nanoparticles against polymicrobial osteomyelitis pathogens.
• To assess the cytocompatibility of the nanoparticle system with human osteoblast cells.

Main Methods:

• Preparation of monodispersed chitosan nanoparticles co-loaded with minocycline and voriconazole.
• Encapsulation efficiency determination for both drugs.
• Thermostability analysis to assess drug interactions within the nanoparticles.
• In vitro anti-biofilm assays using Staphylococcus aureus and Candida albicans.
• Cytotoxicity assays using a human osteoblast cell line.

Main Results:

• Successful preparation of dual-loaded chitosan nanoparticles.
• Minocycline exhibited higher encapsulation efficiency than voriconazole.
• Thermostability analysis indicated potential interactions affecting voriconazole release.
• Significant in vitro reduction (up to 90%) of polymicrobial biofilms.
• Demonstrated cytocompatibility with human osteoblast cells.

Conclusions:

• The developed chitosan nanoparticle system effectively co-delivers antibacterial and antifungal agents.
• The dual-loaded nanoparticles show potent in vitro anti-biofilm activity against key osteomyelitis pathogens.
• This system holds promise as an innovative therapeutic strategy for polymicrobial osteomyelitis.